MARKET

OGN

OGN

ORGANON & CO
NYSE
9.28
-0.49
-4.97%
Opening 15:37 04/20 EDT
OPEN
9.66
PREV CLOSE
9.76
HIGH
9.82
LOW
9.22
VOLUME
5.38M
TURNOVER
--
52 WEEK HIGH
13.12
52 WEEK LOW
5.69
MARKET CAP
2.41B
P/E (TTM)
12.93
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OGN last week (0413-0417)?
Weekly Report · 12h ago
A Look At Organon (OGN) Valuation After VTAMA Wins Key Pediatric Atopic Dermatitis Endorsement
Simply Wall St · 12h ago
Is Organon (OGN) Still A Bargain After Its Recent 57% One Month Surge In Price
Simply Wall St · 2d ago
The 10 Healthcare stocks with the lowest forward P/E ratios
Seeking Alpha · 4d ago
Reported Earlier: 'Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon' - Bloomberg
Benzinga · 4d ago
Organon gains as Sun Pharma, Grünenthal said to seek takeover deals
Seeking Alpha · 4d ago
Press Release: Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026
Dow Jones · 4d ago
Organon Says VTAMA Creamwas Granted Strong, Evidence-Based Recommendation By AAD In 2026 Guidelines For Management And Treatment Of AD In Pediatric Patients, Published On April 7
Benzinga · 5d ago
More
About OGN
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Webull offers Organon & Co stock information, including NYSE: OGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OGN stock methods without spending real money on the virtual paper trading platform.